Fujiwara, Yu
867  Ergebnisse:
Personensuche X
?
2

Endocrine adverse events in patients with cancer receiving ..:

Zhou, Susu ; Horita, Nobuyuki ; Shao, Theresa..
Therapeutic Advances in Medical Oncology.  16 (2024)  - p. , 2024
 
?
4

C-reactive protein (CRP) as a prognostic biomarker in patie..:

Fujiwara, Yu ; Karol, Alexander B. ; Joshi, Himanshu...
Critical Reviews in Oncology/Hematology.  197 (2024)  - p. 104352 , 2024
 
?
5

The Effect of Sodium-Glucose Cotransporter-2 Inhibitors on ..:

Agarwal, Siddharth ; Qamar, Usama ; Fujiwara, Yu...
The American Journal of Cardiology.  216 (2024)  - p. 87-90 , 2024
 
?
 
?
10

Targeting KRAS: Crossroads of Signaling and Immune Inhibiti..:

Kato, Shumei ; Fujiwara, Yu ; Hong, David S.
Journal of Immunotherapy and Precision Oncology.  5 (2022)  3 - p. 68-78 , 2022
 
?
11

Incidence of hepatotoxicity associated with addition of imm..:

Fujiwara, Yu ; Horita, Nobuyuki ; Harrington, Matthew...
Cancer Immunology, Immunotherapy.  71 (2022)  12 - p. 2837-2848 , 2022
 
?
 
?
14

PSInSAR Analysis for Detecting Signs of Landslide Along Exp..:

, In: IGARSS 2022 - 2022 IEEE International Geoscience and Remote Sensing Symposium,
Kusunose, Tomoya ; Susaki, Junichi ; Fujiwara, Yu. - p. 2927-2930 , 2022
 
?
15

Adverse events induced by nivolumab and ipilimumab combinat..:

Somekawa, Kohei ; Horita, Nobuyuki ; Kaneko, Ayami...
Therapeutic Advances in Medical Oncology.  14 (2022)  - p. 175883592110583 , 2022
 
1-15